[ad_1]
Seelos Therapeutics (NASDAQ:SEEL) filed for resale by traders of as much as ~3.4M shares.
The ~3.4M shares are issuable upon train of excellent warrants to buy shares, issued by us to the promoting stockholders on January 30, 2024.
The corporate registering the resale of the shares as required by the securities buy settlement.
The corporate is not going to obtain any of the proceeds from the shares bought by the promoting stockholders, aside from any proceeds from any money train of warrants.
The inventory is marginally increased 0.25% to $1.00 on Monday throughout pre-market hours of buying and selling.
Extra on Seelos Therapeutics
[ad_2]
Source link
